Aminoglycoside Dosing and Monitoring: A Reference
A reference explanation of gentamicin, tobramycin, and amikacin dosing — concentration-dependent killing, extended-interval regimens, and why nephrotoxicity and ototoxicity make measured levels essential.
This page explains the principles behind aminoglycoside dosing. It produces no dose. These drugs require therapeutic drug monitoring, and dosing should be managed by clinical pharmacy or an infectious diseases service using measured serum concentrations.
Formula & Reference
| Variable | Symbol | Formula | Units |
|---|---|---|---|
| Aminoglycoside Dosing and Monitoring: A Reference | — | Concept reference — no dose output | concept |
Step-by-Step Examples
Aminoglycosides work differently from beta-lactams, and this shapes how they are dosed.
- Bacterial killing depends on peak concentration relative to MIC, not on time above MIC
- This favours larger, less frequent doses
- A prolonged post-antibiotic effect means bacteria stay suppressed after concentrations fall
- Extended-interval dosing exploits both properties
- The trough period allows renal tubular cells to clear accumulated drug
Both are serious and one is often permanent.
- Nephrotoxicity is usually reversible and correlates with sustained elevated troughs
- Ototoxicity — both cochlear and vestibular — is frequently permanent
- Vestibular damage can be disabling and is often recognized late
- Risk rises with duration of therapy, cumulative dose, and concurrent nephrotoxins
- Neither toxicity is reliably predicted by any dosing formula
Population formulas set a starting point at best.
- Volume of distribution varies widely with fluid status, oedema, and body composition
- Renal clearance changes during acute illness
- Extended-interval nomograms such as Hartford use a measured level to select the interval
- Multiple-daily-dosing regimens require both peak and trough measurement
- Therapy beyond a few days demands ongoing monitoring, not a fixed calculated regimen
Real-World Applications
Common Mistakes to Avoid
Extended-interval regimens are not validated in pregnancy, endocarditis synergy dosing, severe renal impairment, burns, or ascites, where conventional dosing and monitoring apply.
Aminoglycosides distribute poorly into adipose tissue. Using total body weight produces substantial overdose; adjusted body weight is the usual approach.
Toxicity risk climbs with duration. Courses are kept as short as the infection allows, with levels and renal function checked throughout.